Oktoba 28, 2020, SARS-CoV-2 Antigen Rapid Test Kit na Nanjing Liming Bio-products Co., Ltd. ya karɓi ta US FDA (EUA).Bayan kayan aikin gano antigen na SARS-CoV-2 da aka samu takardar shedar Guatemala da takardar shaidar FDA ta Indonesia, wannan wani babban labari ne mai inganci.

Hoto 1 Wasiƙar karɓar FDA ta Amurka

Hoto 2 Takaddar rijistar Indonesiya na Kit ɗin Gwajin Saurin Antigen SARS-CoV-2

Hoto 3 Takaddun shaida na Guatemala na SARS-CoV-2 Antigen Rapid Kit Kit

Idan aka kwatanta da fasahar gano PCR nucleic acid, tsarin rigakafi ya fi sauƙi don a yi amfani da shi sosai saboda saurin sa, dacewa da fa'ida mara tsada.Don gano maganin rigakafi, lokacin taga na gano antigen ya kasance a baya, wanda ya fi dacewa da farkon gwajin manyan sikelin, kuma Nucleic acid ne kuma gano antibody shima yana da ma'ana mai girma ga binciken asibiti.

Kwatanta fa'idodin hanyar gano acid nucleic da fasahar gano antigen:

	RT-PCR gano nucleic acid	Tsarin Immunological Fasahar Ganewar Antigen
Hankali	Hankali ya fi 95%.A ka'idar, saboda gano nucleic acid na iya haɓaka samfuran ƙwayoyin cuta, hankalinsa ya fi na hanyoyin gano rigakafi.	Hankali ya tashi daga 60% zuwa 90%, hanyoyin rigakafi suna buƙatar ƙananan buƙatun samfurin, kuma sunadaran antigen suna da ƙarfi sosai, don haka hankalin kayan gano antigen ya tabbata.
Musamman	sama da 95%	Fiye da 80%
Gano mai cin lokaci	Za a iya samun sakamakon gwajin fiye da sa'o'i 2, kuma saboda kayan aiki da wasu dalilai, ba za a iya yin saurin dubawa a kan shafin ba.	Samfurin kawai yana buƙatar mintuna 10-15 don samar da sakamako, wanda za'a iya bincika da sauri akan wurin.
Ko don amfani da kayan aiki	Yana buƙatar kayan aiki masu tsada kamar kayan aikin PCR.	Babu kayan aiki da ake buƙata.
Ko aiki guda ɗaya	A'a, duk samfuran batch ne.	Can.
Wahalhalun fasaha na aiki	Mai rikitarwa kuma yana buƙatar ƙwararru.	Mai sauƙi da sauƙi don aiki.
Yanayin sufuri da ajiya	Kai da adanawa a debe 20 ℃.	Yanayin dakin.
Farashin reagent	Mai tsada.	Mai arha

Gwajin saurin Antigen SARS-CoV-2

Kit ɗin gwajin sauri na SARS-CoV-2 Antigen